Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry ReportBioInformant Worldwide, L.L.C. - April 1, 2015 - 175 Pages - SKU: BFM5528824 |
OVERVIEW SUMMARY
Recent months have seen the first iPSC clinical trial in humans, creation of the world’s largest iPSC biobank, major funding awards, a historic challenge to the “Yamanaka Patent”, a Supreme Court ruling affecting industry patent rights, announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific publication trends give clear indicators of what may happen in the industry in 2015 and beyond. Is it worth it to get informed about rapidly-evolving market conditions and identify key ... read the full abstract
Recent months have seen the first iPSC clinical trial in humans, creation of the world’s largest iPSC biobank, major funding awards, a historic challenge to the “Yamanaka Patent”, a Supreme Court ruling affecting industry patent rights, announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific publication trends give clear indicators of what may happen in the industry in 2015 and beyond. Is it worth it to get informed about rapidly-evolving market conditions and identify key ... read the full abstract
More Stem Cell reports by BioInformant Worldwide, L.L.C.
Mesenchymal Stem Cells - Advances & Applications (2018) by BioInformant Worldwide, L.L.C.
MESENCHYMAL STEM CELLS – ADVANCES & APPLICATIONS (2018) Executive SummaryMesenchymal stem cells (MSCs) are multipotent ...
Strategic Development of Neural Stem & Progenitor Cell Products (2018) by BioInformant Worldwide, L.L.C.
Strategic Development of Neural Stem and Progenitor Cell ProductsExecutive Summary Neurogenesis is the process by which neurons are created. This process is most active ...
The Market for Stem Cell Exosomes by BioInformant Worldwide, L.L.C.
The Market for Stem Cell Exosomes
Although long overlooked, exosomes are rapidly gaining momentum as a novel strategy for accessing the therapeutic ...
Market Size Determination for the Cell Therapy CDMO Market by BioInformant Worldwide, L.L.C.
See all reports like this >> Market Size Determination for the Cell Therapy CDMO Market
Among cell therapy companies, the pressure for manufacturing innovation and optimization can incentivize them ...
Since 1998, MarketResearch.com has provided companies with the business intelligence and research they need to make informed decisions.
We provide information on products, trends, regions, demographics, industries and companies from our collection of over 700 research publishers and 400,000 research reports.
About Us
We provide information on products, trends, regions, demographics, industries and companies from our collection of over 700 research publishers and 400,000 research reports.
About Us
